Tech Company Inital Public Offerings
Prometheus Biosciences IPO
Based in San Diego, Prometheus Biosciences is now a public company.
Transaction Overview
Company Name
Announced On
3/12/2021
Transaction Type
IPO
Amount
$139,650,000
Proceeds Purpose
Use of proceeds for the Prometheus Biosciences IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
9410 Carroll Park Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Email Address
Overview
Prometheus Biosciences is a forward-thinking biopharmaceutical company that is dedicated to disrupting the treatment paradigm of GI diseases. We will do this by discovering and developing a broad portfolio of novel precision therapeutics and diagnostics that will meaningfully impact patient care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark McKenna
Chief Financial Officer
Keith Marshall
Chief Medical Officer
Allison Luo
Chief Operating Officer
Lauren Otsuki
Chief Scientific Officer
Laurens Kruidenier
Chief Technical Officer
Olivier Laurent
Vice President
Brian Littlefield
VP - Bus. Development
Robert Armstrong
VP - Bus. Development
Thierry Dervieux
VP - Bus. Development
Michael Walther
VP - Finance
Vika Brough
Browse more venture capital transactions:
Prev: 3/12/2021: Hugging Face venture capital transaction
Next: 3/12/2021: CalciMedica venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs